If you can’t see what you’re looking for, use the search bar below.
OBBI is an active member of the Réseau des Intégrateurs Biothérapie–Bioproduction, a national network of platforms labeled under France 2030. This network fosters collaboration between integrators across France, aiming to accelerate the development and industrialization of advanced biotherapies.
OBBI receives support from the University of Montpellier’s Innovation Hub (PUI) through the IN-Lab Engineering program. This initiative strengthens strategic development within academic platforms, enhancing OBBI’s ability to advance projects, build industrial partnerships, and promote organoid and extracellular vesicle technologies.
OBBI is supported by CeBBOc, a regional initiative dedicated to strengthening the biotherapies sector in Occitanie. Through the co-funding of OBBI’s Business Development role, CeBBOc helps drive partnerships and the transfer of organoid and extracellular vesicle technologies to industry and clinical settings.
OBBI is supported by France 2030, the national investment program accelerating innovation in strategic sectors such as health and biotherapies. As a designated Biotherapy–Bioproduction Integrator, OBBI leverages this support to expand its organoid and extracellular vesicle production capacities, invest in advanced equipment, strengthen quality processes, and drive collaborative projects in next-generation biotherapies.
